Advocates lobbying for passage of International Violence Against Women Act

NewsGuard 100/100 Score

"Supporters of the International Violence Against Women Act (I-VAWA) are ramping up their lobbying efforts as Congress prepares to bring the measure to a vote," The Hill reports. More than a dozen organizations and advocacy groups have written a letter requesting the support of Sen. George Voinovich, R-Ohio. The bill currently has two Republican sponsors in the senate and "advocates say his support will be vital to obtaining the desired amount of funding from Congress: up to $1.3 billion over five years," the newspaper writes.  

The bill is "designed to combat violence against women and girls through all relevant U.S. foreign policy efforts, including international aid programs, and require the administration to produce a strategy designed to 'measurably reduce violence against women,'" The Hill writes. The bill has 28 co-sponsors in the Senate and 112 in the House, and advocates like Ritu Sharma, president and co-founder of Women Thrive Worldwide, are "confident the bill will pass" (Stiles, 7/11).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.